Table 4a.
Risk classification for first postoperative urine IL-18 after addition to clinical model
| Clinical Model | Clinical Model + Urine IL-18 |
Total | ||
|---|---|---|---|---|
| <3% | 3% to 10% | >10% | ||
| AKI participants | ||||
| <3% | 8 (47.1%) | 9 (52.9%) | 0 (0%) | 17 |
| 3% to 10% | 3 (13.6%) | 5 (22.7%) | 14 (63.6%) | 22 |
| >10% | 0 (0%) | 6 (35.3%) | 11 (64.7%) | 17 |
| total | 11 | 20 | 25 | 56 |
| Non-AKI participants | ||||
| <3% | 484 (82.2%) | 105 (17.8%) | 0 (0%) | 589 |
| 3% to 10% | 147 (31.5%) | 231 (49.5%) | 89 (19.1%) | 467 |
| >10% | 4 (4.7%) | 43 (50%) | 39 (45.3%) | 86 |
| total | 635 | 379 | 128 | 1142 |
Clinical model is age (per year), gender, white race, CPB time > 120 minutes, nonelective surgery, preoperative eGFR, diabetes, and hypertension.